Status:

RECRUITING

Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass

Lead Sponsor:

University Hospital, Ghent

Conditions:

Hypoglycemia

Gastric Outlet Obstruction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary objective of this open-label pilot study is to investigate whether an endoscopically placed lumen apposing metal stent is an effective alternative to surgery in patients that have a clear ...

Eligibility Criteria

Inclusion Criteria:

  • Group 1) patients needing any kind of parenteral nutritional support (eg. hypo- albuminemia, hypovitaminoses, mineral deficiencies,...) that can not be corrected by dietary intervention/oral supplementation
  • Group 2) patients with persistent invalidating symptomatic dumping syndrome despite optimal dietary intervention (typical complaints are headache, sweating, trembling, weakness and feeling hungry).
  • Group 3) patients with a refractory marginal ulcers with stenosis of the gastrojejunostomy leading to feading difficulties.
  • Group 4) patients with F3 or F4 liver fibrosis and a tendency to decompensation after bypass surgery, as demonstrated by an increase in serum bilirubin/INR and/or lowering of serum albumin.

Exclusion Criteria:

  1. Uncorrectable coagulopathy

  2. Presence of significant portal hypertension as demonstrated by 2.1) the presence of esophageal and/or gastric varices AND/OR 2.2) a hepatic venous pressure gradient (if measured) equal to or more than 10mm Hg AND/OR 2.3) the combination of

    1. a platelet count <150000/µl AND
    2. liver stiffness measured by elastometry equal to or more than 20 kPa (Baveno guidelines).
  3. Pregnant women, breastfeeding women or women that can not assure adequate anticonception for the duration of the study (based on anamnesis).

  4. Karnofsky index less than 60

  5. Vulnerable patients

Key Trial Info

Start Date :

January 30 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2028

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05640947

Start Date

January 30 2023

End Date

February 1 2028

Last Update

October 8 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

AZ Sint-Jan Brugge

Bruges, Belgium

2

University Hospital, Ghent

Ghent, Belgium, 9000